Pharmaceutical News

RSS

Researchers find major gap in treatment for AF patients at higher risk for stroke

Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being prescribed blood thinners by their cardiologists, according to a new study by researchers at University of California, San Diego School of Medicine and University of California, San Francisco.

17 Mar 2016

WSU researcher explores new drugs to treat neurological disorders linked to autophagic dysfunction

Repairing the brain's "house-cleaning function," which could help people with Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS) and 100 other diseases, is the focus of recently funded research at Washington State University.

17 Mar 2016

Study finds disparities in discontinuing diabetes drug rosiglitazone following FDA safety alert

Among older adults with diabetes, certain subgroups--including white patients and those with lower incomes--were slower to discontinue the diabetes drug rosiglitazone after a US Food and Drug Administration safety alert, reports a study in the April issue of Medical Care.

17 Mar 2016

New study reveals why certain cancer drugs not always effective in halting tumor growth

New cancer drugs allow doctors to tailor treatment based on the genetic profile of a patient's tumor. However, these drugs don't work at all in some patients, and they lose their effectiveness in others.

17 Mar 2016

Biomarkers may provide novel approaches to monitoring immunosuppressive therapy in organ transplant patients

Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients--with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

17 Mar 2016

Hedrin celebrates 10th anniversary with launch of new packaging

Hedrin, the UK’s number 1 head lice brand, is celebrating its 10th birthday with a complete refresh of the packaging, to be available in pharmacies from April.

17 Mar 2016

Johns Hopkins scientists develop antibody to curb lung tumor cell growth, breast cancer metastasis

Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.

17 Mar 2016

Study: Statin drugs can reduce time to clear tuberculosis infection in mice

In a study using mice, the Johns Hopkins University School of Medicine infectious disease experts have added to evidence that statin drugs — known primarily for their cholesterol-lowering effects — can significantly reduce the time it takes to clear tuberculosis infection.

17 Mar 2016

New treatment reduces cerebral damage in out-of-hospital cardiac arrest patients

Among comatose survivors of out-of-hospital cardiac arrest, treatment with inhaled xenon gas combined with hypothermia, compared with hypothermia alone, results in less white matter damage.

16 Mar 2016

Anti-anxiety drug reduces autistic features in Jacobsen syndrome mice

About half of children born with Jacobsen syndrome, a rare inherited disease, experience social and behavioral issues consistent with autism spectrum disorders. Researchers at University of California, San Diego School of Medicine and collaborators developed a mouse model of the disease that also exhibits autism-like social behaviors and used it to unravel the molecular mechanism that connects the genetic defects inherited in Jacobsen syndrome to effects on brain function.

16 Mar 2016

Many kidney transplant patients may benefit from lower-than-standard dose of CNIs

The kidney is the most commonly transplanted organ in the United States, with more than 17,000 transplants performed each year. Following kidney transplant, patients are routinely placed on a regimen of immunosuppressant medications to prevent organ rejection, which often includes calcineurin inhibitors (CNIs) as the backbone medication of this regimen.

16 Mar 2016

Scientists synthesize novel selenohydantoins with anticancer and antioxidant activity

A group of scientists from Moscow universities led by Yan Ivanenkov, the head of Laboratory of Medical Chemistry and Bioinformatics in MIPT, has succeeded in synthesizing a set of novel selenohydantoins with anticancer and antioxidant activity.

16 Mar 2016

Conflicting expectations result in failure of young girls completing HPV vaccinations series

Conflicting expectations between parents and medical providers about who is responsible for scheduling follow-up appointments is resulting in a failure of young girls completing the Human Papilloma Virus (HPV) vaccination series, according to a new study led by Boston Medical Center researchers.

16 Mar 2016

Mindfulness meditation reduces pain without endogenous opioid system

Everyone knows that stubbing your toe hurts. What makes it stop hurting is the body's main pain-blocking process - the natural production of opioids.

16 Mar 2016

Omega-3 fatty acids improve cognitive function in older adults

Changes in cognitive function and memory decline form a normal part of aging. However, in neurodegenerative diseases such as Alzheimer's disease or mild cognitive impairment (the pre-dementia phase of Alzheimer's disease), these changes occur more quickly. There are currently no effective treatments for these diseases.

16 Mar 2016

Oral pill could improve breast cancer diagnostic techniques

The ongoing debate about breast cancer diagnostics has left many women confused — particularly over what age they should get mammograms and who needs treatment. An issue with current methods is that they often identify lumps but cannot conclusively pinpoint which ones are cancerous. To help resolve this uncertainty, researchers have developed a pill that could improve imaging techniques so that only cancerous tumors light up.

15 Mar 2016

Researchers report outcomes of dipyridamole drug in treating pterygium and related dry-eye symptoms

At the Israeli Society for Vision and Eye Research conference on March 10, the MedInsight Research Institute and Center for Drug Repurposing at Ariel University presented the latest findings on positive user-reported outcomes of the repurposed drug dipyridamole in treating pterygium and related dry-eye symptoms.

15 Mar 2016

Pharmaceutical News

Researchers find major gap in treatment for AF patients at higher risk for stroke

WSU researcher explores new drugs to treat neurological disorders linked to autophagic dysfunction

Study finds disparities in discontinuing diabetes drug rosiglitazone following FDA safety alert

New study reveals why certain cancer drugs not always effective in halting tumor growth

Biomarkers may provide novel approaches to monitoring immunosuppressive therapy in organ transplant patients

Hedrin celebrates 10th anniversary with launch of new packaging

Johns Hopkins scientists develop antibody to curb lung tumor cell growth, breast cancer metastasis

Study: Statin drugs can reduce time to clear tuberculosis infection in mice

New treatment reduces cerebral damage in out-of-hospital cardiac arrest patients

Anti-anxiety drug reduces autistic features in Jacobsen syndrome mice

Many kidney transplant patients may benefit from lower-than-standard dose of CNIs

Scientists synthesize novel selenohydantoins with anticancer and antioxidant activity

Conflicting expectations result in failure of young girls completing HPV vaccinations series

Mindfulness meditation reduces pain without endogenous opioid system

Omega-3 fatty acids improve cognitive function in older adults

Oral pill could improve breast cancer diagnostic techniques

Researchers report outcomes of dipyridamole drug in treating pterygium and related dry-eye symptoms

DelMar's VAL-083 receives FDA orphan drug designation for treatment of medulloblastoma

Bruker showcases innovative NMR solutions for pharmaceutical industry at ENC 2015

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News